This insight brief examines how life sciences companies can strengthen commercial performance by adopting a hybrid commercial analytics managed services model. It compares traditional “fully captive” and “vendor captive” approaches, highlighting their limitations in cost transparency, scalability, governance, and access to advanced analytics. The hybrid model combines internal ownership with external expertise through a build-operate-transfer framework, enabling organizations to rapidly deploy analytics capabilities while maintaining control and flexibility. The brief outlines key benefits such as faster time to value, scalable resources, continuous innovation, and improved cost efficiency. It also describes a structured transition framework to operationalize the model effectively. Overall

Join for free to read